BCL2 and breast carcinoma: These results are consistent with previously reported data on gamma-T3 found to inhibit cell proliferation in human breast cancer cells by inducing the expression of Bcl-2 family proteins, and increasing cytochrome c release, caspases-9, and -3 activation and PARP fragmentation [38,64,68].